LIPI.ST - Lipidor AB publ Stock Price & Dividend Safety Sector: Healthcare | Exchange: Stockholm Stock Exchange Current Price & Safety Score Price: 0.68 SEK StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): 4.14 StockBond Score: -2.08 Company Description Lipidor AB publ a pharmaceutical development company engages in the development of drugs for the treatment of psoriasis bacterial skin infections and atopic dermatitis The company develops AKP01 which is in Phase III for the treatment of psoriasis and preclinical stage products such as AKP02 for psoriasis and AKP03 AKP07 for eczema It offers active pharmaceutical ingredients used in products for various therapeutic applications such as antipsoriasic antimicrobial antiinflammatory antifungal local anesthetics nonsteroidal antiinflammatory antiacne wound healing antieczema and antimigraine The company also develops a range of spray products for animal skin care in dogs cats and horses and consumer health care products for applications including antibacterial antiseptic moisturizing emollient disinfectant and acne and wart treatment It has a collaboration agreement with Cannassure Therapeutics Ltd for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions The company was incorporated in 2009 and is based in Danderyd Sweden